Group items matching

in title, tags, annotations or url

A high menaquinone reduces the incidence of coronary heart disease in women.\nGast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, van der Schouw YT.\nNutr Metab Cardiovasc Dis. 2009 Jan 27. [Epub ahead of print]\nPMID: 19179058 \ndoi: 10.1016/j.numecd.2008.10.004\n

Autism and vitamin D. Cannell JJ. Med Hypotheses. 2008;70(4):750-9. Epub 2007 Oct 24. PMID: 17920208

Chatfield SM, Brand C, Ebeling PR, Russell DM. Vitamin D deficiency in general medical inpatients in summer and winter. Intern Med J. 2007 Jun;37(6):377-82. PMID: 17535381 [PubMed - in process]

Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head and Neck Cancer. Corrected Proof, 7 August 2007 Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro, Kauko Saarilahti, Timo Atula, Juhani Collan, Eero Salli, Mika Kortesniemi, Jouni

Fibromyalgia, or FM, is a persistent pain syndrome distinguished by extensive musculoskeletal stiffness, aches and pain, universal tiredness, sleep problems, and soft tissue sensitivity. Fibromyalgia patients undergo a variety of symptoms that come and go

Would you believe that the lettuce you are eating in your dinner salad could possibly be a cure for Type 1 diabetes? A diabetic could be swallowing a capsule containing ground up lettuce with insulin for a few weeks and be cured.

Great article on choosing a wedding reception location

Newmark HL, Newmark J. Vitamin D and Parkinson's disease--a hypothesis. Mov Disord. 2007 Mar 15;22(4):461-8. PMID: 17230473 [PubMed - indexed for MEDLINE]

Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. \nA higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study.\nJ Am Geriatr Soc. 2007 Feb;55(2):234-9.\nPMID: 17302660 [PubMed -

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG; Iowa Women's Health Study. Arthritis Rheum. 2004 Jan;50(1):72-7. PMID: 14730601 DOI: 10.1002/art.11434 CONCLUSION: Greater intake of vitamin D may be associated with a lower risk of RA in older women, although this finding is hypothesis generating.

Conclusions/interpretation These results show that the previously demonstrated beneficial effects of these agents on complication-causing pathways in rodent models of diabetic complications also occur in humans with type 1 diabetes. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Du X, Edelstein D, Brownlee M. Diabetologia. 2008 Oct;51(10):1930-2. Epub 2008 Jul 29. PMID: 18663426 DOI: 10.1007/s00125-008-1100-2

Current drug options for obesity are limited; however, two new weightloss drugs - Contrave and Qnexa - have recently reported positive results in late-stage trials. Availability is expected soon

Allergen Immunotherapy helps alleviate symptoms of hay fever and reduces medication needs. Oral sublingual immunotherapy is more patient-friendly and likely to be used more than traditional injections.

Lorcaserin is one of the most advanced antiobesity drugs in clinical development; two others include Qnexa and Contrave. With late-stage trials having reported results for each of these drugs this year, many analysts are sceptical that lorcaserin will be approved by authorities, as major trial results indicate this drug may only just meet the FDA criterion for weight management.

Isentress is a new HIV treatment in development. Recent studies have shown Isentress-based therapy maintains activity at 96 weeks in treatment-naïve HIV patients, comparable to efavirenz, which is a current favourite for this patient pool. The benefits of Isentress-based therapy, however, are improved side effect and lipid profiles.

Another of my new Year's resolutions put into an informative article! Read this to learn why, it may save your life.

The U.S. FDA ordered 21 manufacturers to collect information from patients in a recent letter to hip manufacturers. Click here for report. The three-page letter demands blood tests and other studies within thirty days. Here is a summary of the information and questions the FDA is requiring from manufacturers: